574 related articles for article (PubMed ID: 31776268)
1. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
2. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
3. Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins.
Lo Cigno I; Calati F; Albertini S; Gariglio M
Pathogens; 2020 Apr; 9(4):. PubMed ID: 32316236
[TBL] [Abstract][Full Text] [Related]
4. Activation of telomerase by HPVs.
Katzenellenbogen RA
Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus E7 oncoprotein as a regulator of transcription.
Songock WK; Kim SM; Bodily JM
Virus Res; 2017 Mar; 231():56-75. PubMed ID: 27818212
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M
J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055
[TBL] [Abstract][Full Text] [Related]
7. HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ
Albertini S; Lo Cigno I; Calati F; De Andrea M; Borgogna C; Dell'Oste V; Landolfo S; Gariglio M
J Immunol; 2018 Mar; 200(6):2076-2089. PubMed ID: 29386255
[TBL] [Abstract][Full Text] [Related]
8. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
9. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
10. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
[TBL] [Abstract][Full Text] [Related]
11. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes.
Richards KH; Wasson CW; Watherston O; Doble R; Eric Blair G; Wittmann M; Macdonald A
Sci Rep; 2015 Aug; 5():12922. PubMed ID: 26268216
[TBL] [Abstract][Full Text] [Related]
13. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects.
Lo Cigno I; Calati F; Girone C; Catozzo M; Gariglio M
J Med Virol; 2024 Jun; 96(6):e29685. PubMed ID: 38783790
[TBL] [Abstract][Full Text] [Related]
14. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.
Hong S; Mehta KP; Laimins LA
J Virol; 2011 Sep; 85(18):9486-94. PubMed ID: 21734056
[TBL] [Abstract][Full Text] [Related]
15. Human papillomaviruses target the double-stranded RNA protein kinase pathway.
Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA
J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
18. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
19. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
[TBL] [Abstract][Full Text] [Related]
20. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
